August 26, 1994 |
Drug Production Interrupted at Amgen: The company said it has curtailed production of Epogen, one of its two main drugs, while it upgrades the water-filtering system at its Thousand Oaks factory. Amgen, the world's largest biotechnology company in terms of sales, said it expects to restart the system early next week and resume full production of Epogen within days after that.
April 24, 2007 |
All things considered, Gary K. Melton should have listened to his wife. That's what Melton's attorney conceded Monday after his client agreed to pay about $31,000 to settle insider trading charges brought by the Securities and Exchange Commission. Melton's wife, Farryn Melton, is vice president of strategic sourcing and procurement at Thousand Oaks-based Amgen Inc., where she had access to confidential information, according to the SEC.
April 28, 1998 |
Thousand Oaks-based Amgen Inc. will pay Johnson & Johnson $205 million to compensate for Amgen sales of an anemia drug for uses reserved to Johnson & Johnson in a licensing agreement. The arbitration ends an eight-year dispute stemming from a 1985 sales agreement that limits Amgen's U.S. sales of its Epogen drug to use in kidney dialysis patients.
May 14, 2002 |
Amgen Inc. and the Food and Drug Administration warned that counterfeit vials of Epogen, an anemia drug given to dialysis patients, have been discovered. Letters have been sent to doctors, pharmacists and drug wholesalers to alert them to the problem, which was announced on the Web sites of the FDA and Amgen, the maker of Epogen, on Wednesday. The letters say the counterfeit vials contain Epogen's active ingredient, but the concentration is about 20 times lower than it should be.
CALIFORNIA | LOCAL
September 25, 2002 |
Bruce Wallace, a distinguished biologist and one of the first employees of biotech giant Amgen, was killed last week when his paraglider crashed into a cliff face near Mt. Whitney in the Sierra Nevada range. The 54-year-old Ojai resident, known for his dry wit and adventurous spirit, was flying at 12,000 feet Friday when the accident occurred, according to the Inyo County Sheriff's Department.
November 3, 2005 |
Amgen Inc. on Wednesday signed on as title sponsor of the 750-mile Tour of California, one of the biggest cycling races in the United States. The Thousand Oaks-based biotechnology giant said it hoped to use its sponsorship to draw attention to legitimate uses of its anemia drugs, which are sometimes abused by competitive cyclists seeking to enhance their performances.